Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients
Background: Somatic mutations in isocitrate dehydrogenase 1 (IDH1) gene occur frequently in primary brain tumors. Recently theses mutations were demonstrated in acute myeloid leukemia (AML). So far, assessment of these mutations relied on the DNA sequencing technique. Aim of the work: The aim of thi...
Main Authors: | Ghada M. Elsayed, Hanan R. Nassar, Amr Zaher, Essam H. Elnoshokaty, Manar M. Moneer |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2014-03-01
|
Series: | Journal of the Egyptian National Cancer Institute |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110036213001106 |
Similar Items
-
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01) -
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
by: Xiaoyan Liu, et al.
Published: (2019-10-01) -
Detection of hotspot mutations in IDH1/2 in patients withacute myeloid leukemia using Droplet Digital PCR
by: Wågberg, Johanna
Published: (2020) -
Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients
by: Susanna Grassi, et al.
Published: (2020-06-01) -
Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia
by: Ashkan Emadi, et al.
Published: (2016-03-01)